Match tier Listed
Presence Formerly Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-08-16

Ravi P. Cholia

Research Instructor

UAMS

Formerly Arkansas Affiliated with UAMS through 2022; recent publications list Massachusetts College of Pharmacy and Health Sciences.

Faculty Researcher

7 h-index 10 pubs 327 cited

Research Areas

Biomedical Subjects

  • Humans
  • Animals
  • DNA-(Apurinic or Apyrimidinic Site) Lyase
  • Neoplasms
  • Glioblastoma
  • Cell Line, Tumor
  • DNA Repair
  • Oxidative Stress
  • Molecular Targeted Therapy
  • Phytochemicals
  • Lysophospholipase D
  • Phosphoric Diester Hydrolases
  • Signal Transduction
  • Rats
  • Antineoplastic Agents

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Ravi P. Cholia's research investigates the molecular mechanisms underlying cancer, with a particular focus on glioblastoma multiforme. His work has explored the role of pyruvate kinase (PKM2) in glioblastoma progression and examined potential therapeutic interventions. Cholia has also studied the neuroprotective effects of nicotinamide riboside, specifically its ability to alleviate cisplatin-induced peripheral neuropathy through SIRT2 activation. His research utilizes animal models and cell lines to understand disease processes and evaluate treatment strategies. Cholia has published 10 papers, accumulating 327 citations, and holds an h-index of 7. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Ratan Sadhukhan, Mousumi Patra, Fen Xia, and Wuying Du.

Metrics

  • h-index: 7
  • Publications: 10
  • Citations: 327

Selected Publications

  • Nicotinamide Riboside Alleviates Cisplatin-Induced Peripheral Neuropathy via SIRT2 Activation (2022)
    International Journal of Radiation Oncology*Biology*Physics DOI OpenAlex
  • Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation (2022)
    Neuro-Oncology Advances 7 citations DOI OpenAlex
  • A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme (2021)
    Metabolic Brain Disease 25 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

  • The novel role of Sirtuin 2 in regulation of transcription-associated DNA damage repair NIH

Collaboration Network

13 Collaborators 3 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics

Wuying Du University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research Neurological disorders and treatments Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
Hannah Stovall Hendrix College
Cancer-related molecular mechanisms research Pharmacological Effects and Toxicity Studies Mitochondrial Function and Pathology
Good match 3 shared topics
Abdelrahman Y. Fouda University of Arkansas for Medical Sciences
Neurological disorders and treatments Pharmacological Effects and Toxicity Studies Mitochondrial Function and Pathology
Good match 4 shared topics
J. Leung University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research Pharmacological Effects and Toxicity Studies DNA Repair Mechanisms
Good match 3 shared topics
Meenakshi Upreti University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research Pharmacological Effects and Toxicity Studies Animal, Disease Models
Good match 3 shared topics
Joe M. Fowler National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies Mitochondrial Function and Pathology DNA Repair Mechanisms
Good match 3 shared topics